chr20-50935242-T-TA
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_003859.3(DPM1):c.679-7_679-6insT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0256 in 1,541,218 control chromosomes in the GnomAD database, including 1,645 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.10 ( 1377 hom., cov: 29)
Exomes 𝑓: 0.019 ( 268 hom. )
Consequence
DPM1
NM_003859.3 splice_region, intron
NM_003859.3 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0770
Publications
3 publications found
Genes affected
DPM1 (HGNC:3005): (dolichyl-phosphate mannosyltransferase subunit 1, catalytic) Dolichol-phosphate mannose (Dol-P-Man) serves as a donor of mannosyl residues on the lumenal side of the endoplasmic reticulum (ER). Lack of Dol-P-Man results in defective surface expression of GPI-anchored proteins. Dol-P-Man is synthesized from GDP-mannose and dolichol-phosphate on the cytosolic side of the ER by the enzyme dolichyl-phosphate mannosyltransferase. Human DPM1 lacks a carboxy-terminal transmembrane domain and signal sequence and is regulated by DPM2. Mutations in this gene are associated with congenital disorder of glycosylation type Ie. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 20-50935242-T-TA is Benign according to our data. Variant chr20-50935242-T-TA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 338752.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.357 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DPM1 | NM_003859.3 | c.679-7_679-6insT | splice_region_variant, intron_variant | Intron 8 of 8 | ENST00000371588.10 | NP_003850.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.102 AC: 12651AN: 124268Hom.: 1369 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
12651
AN:
124268
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0298 AC: 7020AN: 235258 AF XY: 0.0263 show subpopulations
GnomAD2 exomes
AF:
AC:
7020
AN:
235258
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0189 AC: 26737AN: 1416894Hom.: 268 Cov.: 21 AF XY: 0.0184 AC XY: 13012AN XY: 707286 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
26737
AN:
1416894
Hom.:
Cov.:
21
AF XY:
AC XY:
13012
AN XY:
707286
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
6501
AN:
30266
American (AMR)
AF:
AC:
1028
AN:
43224
Ashkenazi Jewish (ASJ)
AF:
AC:
968
AN:
25438
East Asian (EAS)
AF:
AC:
669
AN:
39238
South Asian (SAS)
AF:
AC:
1898
AN:
83828
European-Finnish (FIN)
AF:
AC:
540
AN:
53160
Middle Eastern (MID)
AF:
AC:
118
AN:
5548
European-Non Finnish (NFE)
AF:
AC:
13112
AN:
1077508
Other (OTH)
AF:
AC:
1903
AN:
58684
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.388
Heterozygous variant carriers
0
1053
2106
3159
4212
5265
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
600
1200
1800
2400
3000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.102 AC: 12678AN: 124324Hom.: 1377 Cov.: 29 AF XY: 0.0991 AC XY: 6013AN XY: 60704 show subpopulations
GnomAD4 genome
AF:
AC:
12678
AN:
124324
Hom.:
Cov.:
29
AF XY:
AC XY:
6013
AN XY:
60704
show subpopulations
African (AFR)
AF:
AC:
10233
AN:
28202
American (AMR)
AF:
AC:
607
AN:
12882
Ashkenazi Jewish (ASJ)
AF:
AC:
156
AN:
3112
East Asian (EAS)
AF:
AC:
132
AN:
4512
South Asian (SAS)
AF:
AC:
155
AN:
4362
European-Finnish (FIN)
AF:
AC:
149
AN:
8670
Middle Eastern (MID)
AF:
AC:
10
AN:
264
European-Non Finnish (NFE)
AF:
AC:
1090
AN:
59752
Other (OTH)
AF:
AC:
146
AN:
1764
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
474
947
1421
1894
2368
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Dec 30, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Congenital disorder of glycosylation Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Congenital disorder of glycosylation type 1E Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.